NSE: AARTIIND | BSE: 524208

Mid-range Performer

Download real time

441.30 3.90 (0.89%)

42.35% Fall from 52W High

1.6M NSE+BSE Volume

NSE 20 Jun, 2025 3:53 PM (IST)

15,998

Market Cap

High in industry

1.5

Beta 1Year

Very High Volatility

Aarti Industries Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for AARTIIND, BSE:524208 Aarti Industries Ltd.

Aarti Industries Ltd.

13 Nov 2020

441.30

0.89%

Light House Update - A Quick Perspective - Aarti Industries Ltd. - 13 November 2020

Accumulate: Aarti Industries Ltd.

Way2Wealth

Aarti Industries Ltd reported ~19% YoY and ~25% QoQ increase in topline to `11,726mn on account of 24% YoY and 32% QoQ increase in specialty chemicals segment and ~21% YoY and 14% QoQ increase in pharmaceuticals. EBITDA for the quarter stood at `2543mn showcasing growth of ~0.5% YoY and 39% QoQ. However, EBITDA margins dropped to 21.7% in Q2FY21 compared to...

Aarti Industries Ltd.'s price crossed below 50Day SMA today

Aarti Industries Ltd.

12 Nov 2020

441.30

0.89%

Aarti Industries

Buy: Aarti Industries Ltd.

Target

ICICI Securities Limited

The company is a preferred partner for customers from multiple industries for benzene-chain based solutions due to strong chemistry prowess, backward integration, larger products basket that is backed by continuous innovation and leadership position in its key products. It is the only domestic player to have products until the sixth level derivative of benzene chemistry. It also expects to leverage on its existing clientele to promote its toluene and other derivatives. Most contracts are long term cost+ contracts that offer better control on the overall cost structure. Recently, it signed three...

Aarti Industries Ltd. has an average target of 540.83 from 6 brokers.

Aarti Industries Ltd.

12 Nov 2020

441.30

0.89%

Result Update:Aarti Industries

Buy: Aarti Industries Ltd.

Target

Axis Direct

For Q2FY21, Aarti Industries (AIL) sales were ahead of our Revenue/EBITDA/PAT estimates. Consol Income from Operations stood at Rs. 1,173cr (Rs. 1,108cr our estimate) higher by 9% YoY driven by strong 24% YoY growth in Specialty Chemical and 22% growth in Pharma sales.

Aarti Industries Ltd. is trading below its 30 day SMA of 469.8

Aarti Industries Ltd.

12 Nov 2020

441.30

0.89%

AARTI INDUSTERIES LTD

Accumulate: Aarti Industries Ltd.

Recommendation Target

Geojit BNP Paribas

EBITDA margins declined by 190bps YoY due to weak product mix and higher cost. Consequently, PAT was down by 5% YoY. Revival in discretionary portfolio, ~40% of specialty chemicals...

Aarti Industries Ltd. is trading above its 150 day SMA of 430.9

Aarti Industries Ltd.

12 Nov 2020

441.30

0.89%

Aarti Ind

Buy: Aarti Industries Ltd.

Recommendation Target

East India Securities Ltd

for margin improvement. However, we believe current valuations already discount most of the remained flattish to Rs2.54bn in Q2FY21 (vs our estimate of Rs2.24bn in Q2FY21). Lower positives of the better product mix, growth at export front and margin improvement and hence other income has led PBT to report a de-growth of 3.1% YoY to Rs1.77bn in Q2FY21. PAT offer limited upside from here. We assign accumulate rating with target price of Rs. 474...

Aarti Industries Ltd. has lost -35.60% in the last 1 Year

Aarti Industries Ltd.

11 Nov 2020

441.30

0.89%

Aarti Ind

Buy: Aarti Industries Ltd.

Target

Dolat Capital

Aarti Industries reported consolidated sales growth of 18.7% YoY to Rs 11.7bn (D.est: Rs 9.88bn), which were ahead of our estimates as the company was able to recoup volumes in the domestic market (which are expected to reach pre-covid levels in 3QFY21). EBITDA was flat at Rs 2.54bn, with an EBITDA margin of 21.7% (down 403 bps YoY). Margins remained under pressure as bulk of the discretionary application sales witnessed realisation pressure coupled with lower sales coming from regulated markets (wherein margins...

Aarti Industries Ltd.'s price crossed below 50Day SMA today

Aarti Industries Ltd.

28 Oct 2020

441.30

0.89%

Aarti Industries Ltd

Accumulate: Aarti Industries Ltd.

Recommendation Target

CD Equisearch

Strangled by pandemic induced lockdown which all but decimated supply networks and brought factory production to a grinding halt in April and some part of May, Aarti report 50% drop in its speciality chemicals production in April, thus precipitating some 11% decline in its gross speciality chemicals revenues (consolidated) in Q1 (yoy). Whence speciality chemicals EBIT plunged by a distressing 39.2% not least due to lower sales and higher expenses on account of commissioning of first phase of Dahej SEZ and R&D; Centre at Navi Mumbai in Q4, thus little protected by...

Aarti Industries Ltd. is trading above its 150 day SMA of 430.9

Aarti Industries Ltd.

16 Oct 2020

441.30

0.89%

BP Equities Chemical Sector Result Preview Q2 FY21

Hold: Aarti Industries Ltd.

BP Wealth

Aarti Industries Ltd. is trading above its 150 day SMA of 430.9

Aarti Industries Ltd.

09 Oct 2020

441.30

0.89%

Aarti Industries

Buy: Aarti Industries Ltd.

ICICI Securities Limited

Aarti Industries Ltd. is trading above its 150 day SMA of 430.9

Aarti Industries Ltd.

08 Sep 2020

441.30

0.89%

Aarti Industries Ltd

Buy: Aarti Industries Ltd.

Rudra Shares and Stock Brokers Ltd

As per management, Q1 performance was largely in line with expectations and the outlook shared previously. During the quarter, Specialty Chemicals production in April was at about 50%, which subsequently ramped up to 80% in the month of...

Aarti Industries Ltd. has an average target of 540.83 from 6 brokers.

Is Aarti Industries Ltd. worth buying?

872 Votes:

Buy 80.73%

Sell 11.47%

Hold 7.8%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf